Trial intelligence / Profile preview

CIPAMI-Study: Prehospital clopidogrel to improve primary PCI in STEMI

2006-000516-24Phase 3Completed

Sponsor
Institut für Herzinfarktforschung
Start
May 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of clopidogrel in myocardial infarction (MI), sponsored by Institut für Herzinfarktforschung. Primary endpoint: TIMI 2/3 patency of the infarct-related artery immediately prior to PCI. Started May 2006; status: completed.

02

Drugs

clopidogrel
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on 2006-000516-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000516-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call